Literature DB >> 12493812

Linezolid resistance in clinical isolates of Staphylococcus aureus.

Peter Wilson, J A Andrews, R Charlesworth, R Walesby, M Singer, D J Farrell, M Robbins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12493812     DOI： 10.1093/jac/dkg104

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  64 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci.

Authors:  Alistair Sinclair; Catherine Arnold; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

3.  Linezolid in VAP by MRSA: a better choice?

Authors:  Malina Ioanas; Hartmut Lode
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

4.  Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation.

Authors:  Tao Hong; Xiangyang Li; Jie Wang; Cynthia Sloan; Cristina Cicogna
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

5.  In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.

Authors:  Cédric Jacqueline; Dominique Navas; Eric Batard; Anne-Françoise Miegeville; Virginie Le Mabecque; Marie-France Kergueris; Denis Bugnon; Gilles Potel; Jocelyne Caillon
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection.

Authors:  Charles J Gill; George K Abruzzo; Amy M Flattery; Andrew S Misura; Ken Bartizal; Emily J Hickey
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

7.  Novel Staphyloxanthin Inhibitors with Improved Potency against Multidrug Resistant Staphylococcus aureus.

Authors:  Shuaishuai Ni; Baoli Li; Feifei Chen; Hanwen Wei; Fei Mao; Yifu Liu; Yixiang Xu; Xiaoxi Qiu; Xiaokang Li; Wenwen Liu; Linghao Hu; Dazheng Ling; Manjiong Wang; Xinyu Zheng; Jin Zhu; Lefu Lan; Jian Li
Journal:  ACS Med Chem Lett       Date:  2018-02-22       Impact factor: 4.345

8.  Pharmacokinetics of linezolid in septic patients with and without extended dialysis.

Authors:  Stefanie Swoboda; Michael C Ober; Christoph Lichtenstern; Soundos Saleh; Vedat Schwenger; Hans-Günther Sonntag; Walter Emil Haefeli; Georg Hempel; Torsten Hoppe-Tichy; Markus A Weigand
Journal:  Eur J Clin Pharmacol       Date:  2009-12-16       Impact factor: 2.953

9.  R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.

Authors:  Eugene Skripkin; Timothy S McConnell; Joseph DeVito; Laura Lawrence; Joseph A Ippolito; Erin M Duffy; Joyce Sutcliffe; François Franceschi
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

10.  Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Authors:  Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.